IL18 and breast carcinoma: Caspase-1 in parenchymal cells of the tumor was negatively correlated with tumor progression, and upregulation of IL-18 in immune-stromal cells of breast cancer tissues is a potential immunotherapy target and a promising prognostic biomarker in this study.